Role of hydrogen sulfide in the physiology of penile erection

Journal of Andrology

Volumn 33, Issue 4, 2012, Pages 529-535

  Qiu, Xuefeng ^a,b   Villalta, Jackie ^a   Lin, Guiting ^a   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NANJING UNIVERSITY   (China)

Author keywords

Corpus cavernosum; Erectile dysfunction; Smooth muscle

Indexed keywords

3 MERCAPTOPYRUVATE SULFURTRANSFERASE; AMINOTRANSFERASE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE AMINOTRANSFERASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; HYDROGEN SULFIDE; SULFURTRANSFERASE; UNCLASSIFIED DRUG;

BIOSYNTHESIS; CELL PROLIFERATION; CORPUS CAVERNOSUM; ENDOTHELIUM CELL; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE;

ERECTILE DYSFUNCTION; HUMANS; HYDROGEN SULFIDE; MALE; PENILE ERECTION; PENIS; PHOSPHODIESTERASE 5 INHIBITORS;

EID: 84860762619     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.111.014936     Document Type: Review

References (53)

1. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996;16:1066-1071.
2. Albersen M, Fandel TM, Zhang H, Banie L, Lin G, De Ridder D, Lin CS, Lue TF. Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction. Eur Urol. 2011a;59:286-296.
3. Albersen M, Mwamukonda KB, Shindel AW, Lue TF. Evaluation and treatment of erectile dysfunction. Med Clin North Am. 2011b;95: 201-212.
4. Bianca RDD, Sorrentino R, Maffia P, Mirone V, Imbimbo C, Fusco F, De Palma R, Ignarro LJ, Cirino G. Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation. Proc Natl Acad Sci U S A. 2009;106:4513-4518.
5. Boehning D, Snyder SH. Novel neural modulators. Annu Rev Neurosci. 2003;26:105-131.
6. Boulton AJ, Selam JL, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia. 2001;44:1296-1301.
7. Briganti A, Salonia A, Deho' F, Zanni G, Barbieri L, Rigatti P, Montorsi F. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction. World J Urol. 2005;23:374-384.
8. Burnett AL. Novel nitric oxide signaling mechanisms regulate the erectile response. Int J Impot Res. 2004;16:S15-S19.
9. Carson CC, Lue TF. Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int. 2005;96:257-280.
10. Christ GJ, Lue T. Physiology and biochemistry of erections. Endocrine. 2004;23:93-100.
11. Diwakar L, Ravindranath V. Inhibition of cystathionine-gamma-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int. 2007;50:418-426.
12. El-Sakka AI, Lue TF. Physiology of penile erection. ScientificWorld-Journal. 2004;4(suppl 1):128-134.
13. Gadalla MM, Synder SH. Hydrogen sulfide as a gasotransmitter. J Neurochem. 2010;113:14-26.
14. Geng B, Chang L, Pan CS, Qi YF, Zhao J, Pang YZ, Du JB, Tang CS. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun. 2004;318:756-763.
15. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338:1397-1404.
16. Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med. 2010;7:445-475.
17. Griffith OW. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem. 1982;257:3704-3712.
18. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun. 1997;237:527-531.
19. 2S). Free Radic Biol Med. 2009;46:616-623.
20. Kendirci M, Hellstrom WJ. Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin Prostate Cancer. 2004;3:87-92.
21. Kimura H. Hydrogen sulfide: its production and function. Exp Physiol. 2011;96:833-835.
22. Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004;18:1165-1167.
23. Lin CS, Xin ZC, Wang Z, Deng C, Huang YC, Lin G, Lue TF. Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev. 2012;21:343-351.
24. Lue TF. Drug therapy: erectile dysfunction. N Engl J Med. 2000;342:1802-1813.
25. Meng QH, Yang GD, Yang W, Jiang B, Wu LY, Wang R. Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol. 2007;170:1406-1414.
26. Moore PK, Bhatia M, Moochhala S. Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol Sci. 2003;24:609-611.
27. Papapetropoulos A, Pyriochou A, Altaany Z, Yang GD, Marazioti A, Zhou ZM, Jeschke MG, Branski LK, Herndon DN, Wang R, Szabo C. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A. 2009;106:21972-21977.
28. Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. 2011;50:567-575.
29. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA. 1999; 281:421-426.
30. Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC. Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through proteinkinase G-dependent generation of hydrogen sulfide. Circulation. 2009;120:S31-S36.
31. Searcy DG, Lee SH. Sulfur reduction by human erythrocytes. J Exp Zool. 1998;282:310-322.
32. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem. 2009a;146:623-626.
33. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, Kimura H. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal. 2009b;11:703-714.
34. Shin D, Pregenzer Jr G, Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev. 2011;19:5-11.
35. Shukla N, Rossoni G, Hotston M, Sparatore A, Del Soldato P, Tazzari V, Persad R, Angelini GD, Jeremy JY. Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int. 2009;103:1522-1529.
36. Srilatha B, Adaikan PG, Li L, Moore PK. Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function. J Sex Med. 2007;4:1304-1311.
37. Srilatha B, Adaikan PG, Moore PK. Possible role for the novel gasotransmitter hydrogen sulphide in erectile dysfunction-a pilot study. Eur J Pharmacol. 2006;535:280-282.
38. Streng T, Axelsson HE, Hedlund P, Andersson DA, Jordt SE, Bevan S, Andersson KE, Högestätt ED, Zygmunt PM. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol. 2008;53:391-399.
39. Strobel NA, Fassett RG, Marsh SA, Coombes JS. Oxidative stress biomarkers as predictors of cardiovascular disease. Int J Cardiol. 2011;147:191-201.
40. Tang C, Li X, Du J. Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr Vasc Pharmacol. 2006;4:17-22.
41. Teague B, Asiedu I, Moore PK. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol. 2002;137:139-145.
42. Vitvitsky V, Thomas M, Ghorpade A, Gendelman HE, Banerjee R. A functional transsulfuration pathway in the brain links to glutathione homeostasis. J Biol Chem. 2006;281:35785-35793.
43. Wagner CA. Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator. J Nephrol. 2009;22:173-176.
44. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J. 2002;16:1792-1798.
45. Weinhold P, Gratzke C, Streng T, Stief C, Andersson KE, Hedlund P. TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation. J Urol. 2010;183:2070-2076.
46. Yan SK, Chang TJ, Wang H, Wu LY, Wang R, Meng QH. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun. 2006;351:485-491.
47. Yang GD, Sun XF, Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogenactivated protein kinases and caspase-3. FASEB J. 2004;18: 1782-1784.
48. Yang GD, Wu LY, Bryan S, Khaper N, Mani S, Wang R. Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovasc Res. 2010;86:487-495.
49. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 2008;322:587-590.
50. Yang Y, Hayden MR, Sowers S, Bagree SV, Sowers JR. Retinal redox stress and remodeling in cardiometabolic syndrome and diabetes. Oxidative Med Cell Longev. 2010;3:392-403.
51. Zhang XH, Melman A, Disanto ME. Update on corpus cavernosum smooth muscle contractile pathways in erectile function: a role for testosterone? J Sex Med. 2011;8:1865-1879.
52. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 2001;20:6008-6016.
53. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol. 2002;283:H474-H480.